Novel Approaches to Head and Neck Cancer at Vanderbilt Ingram Cancer Center

Speakers at an Institute for Value-Based Medicine event with Vanderbilt University Medical Center highlighted the novel therapies and techniques being used to improve outcomes for patients with head and neck cancer.

Related Keywords

United States ,Vanderbilt University ,Tennessee ,American ,Michael Topf ,Eben Rosenthal ,Jennifer Choe ,Sarah Rohde ,Neck Surgery Division ,Department Of Otolaryngology ,Vanderbilt Ingram Cancer Center ,Institute For Value ,Vanderbilt University Medical Center ,American Journal ,Managed Care ,Neck Oncologic Surgery ,Neck Surgery ,Immuno Oncology ,Head And Neck Cancer ,Cemiplimab ,Pembrolizumab ,Avelumab ,Pd 1 ,Pd L1 ,